1. Home
  2. JSPR

JSPR

Jasper Therapeutics Inc.

Logo Jasper Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-17-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Founded: 2018 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 417.6M IPO Year: N/A
Target Price: $64.79 AVG Volume (30 days): 129.0K
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.18 EPS Growth: N/A
52 Week Low/High: $4.00 - $31.01 Next Earning Date: 05-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: